This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Skye Bioscience Securities Fraud Lawsuit
Business class action lawsuit

Skye Bioscience Securities Fraud Lawsuit

Analysis based on 22 articles · First reported Nov 24, 2025 · Last updated Jan 09, 2026

Sentiment
-50
Attention
4
Articles
22
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The class action lawsuit against Skye Bioscience for alleged securities fraud is expected to negatively impact its stock price and investor confidence. For law firms like Levi & Korsinsky and The Gross Law Firm, this event presents a business opportunity to represent aggrieved shareholders.

Biotechnology Legal Services
Event Summary

Skye Bioscience, a publicly traded company, is facing multiple class action securities lawsuits filed by law firms including Levi & Korsinsky and The Gross Law Firm. The lawsuits allege that Skye Bioscience made false and misleading statements to investors between November 4, 2024, and October 3, 2025, regarding the effectiveness and commercial prospects of its lead product candidate, nimacimab. Investors who suffered losses during this period are encouraged to join the lawsuit, with a lead plaintiff deadline set for January 16, 2026. Joseph E. Levi is a key contact person for Levi & Korsinsky in this matter.

Entities Involved
stock
Skye Bioscience
Skye Bioscience is the defendant in a class action securities lawsuit, accused of making false and misleading statements regarding the effectiveness and prospects of its lead product candidate, nimacimab. This event negatively impacts its stock price and reputation.
Importance 100.0 Sentiment -70.0
priv
Levi & Korsinsky
Importance 0.0 Sentiment 0.0
per
Joseph E. Levi
Importance 0.0 Sentiment 0.0
Relationships
Levi & Korsinsky related ↔ Joseph E. Levi
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.